Novel Systemic and Topical Treatments for Plaque Psoriasis - Episode 1

Novel Systemic and Topical Treatment for Plaque Psoriasis

Published on: 
, ,

In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis

1:06 Therapeutic innovations in psoriasis

6:55 Challenges with individualizing treatment

7:51 Selective mechanism of deucravacitinib (TYK2 inhibitor)

11:25 Clinical outcomes of deucravacitinib in psoriasis

15:38 Positioning deucravacitinib in the treatment algorithm

17:58 Deucravacitinib vs apremilast

21:41 Novel non-steroidal topicals- tapinarof and roflumilast

26:06 Efficacy and safety of novel topicals

32:13 Benefits of topicals with cross indications

33:55 Remittive effect of tapinarof

37:08 Summary of novel treatments in psoriasis

39:45 Personalizing psoriasis treatment